Business Description
![Immunome Inc Immunome Inc logo](https://static.gurufocus.com/logos/0C0000BYIN.png?14)
Immunome Inc
NAICS : 541714
SIC : 2833
ISIN : US45257U1088
Share Class Description:
IMNM: Ordinary SharesDescription
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 190.59 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 9.92 | |||||
Beneish M-Score | -0.36 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.5 | |||||
3-Year EPS without NRI Growth Rate | 28.8 | |||||
3-Year FCF Growth Rate | 51.7 | |||||
3-Year Book Growth Rate | -10.7 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.91 | |||||
9-Day RSI | 37.89 | |||||
14-Day RSI | 37.29 | |||||
6-1 Month Momentum % | 23.54 | |||||
12-1 Month Momentum % | 82.15 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.18 | |||||
Quick Ratio | 10.18 | |||||
Cash Ratio | 10.07 | |||||
Days Sales Outstanding | 18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -59.6 | |||||
Shareholder Yield % | -31.75 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -351.67 | |||||
Net Margin % | -1829.44 | |||||
FCF Margin % | -479.44 | |||||
ROE % | -266.86 | |||||
ROA % | -178.21 | |||||
ROIC % | -214.71 | |||||
ROC (Joel Greenblatt) % | -1659.67 | |||||
ROCE % | -42.55 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 14.62 | |||||
PB Ratio | 2.53 | |||||
Price-to-Tangible-Book | 2.54 | |||||
EV-to-EBIT | -9.39 | |||||
EV-to-EBITDA | -9.57 | |||||
EV-to-Revenue | 33.02 | |||||
EV-to-FCF | -6.89 | |||||
Price-to-Net-Current-Asset-Value | 2.59 | |||||
Price-to-Net-Cash | 2.62 | |||||
Earnings Yield (Greenblatt) % | -10.65 | |||||
FCF Yield % | -8.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IMNM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immunome Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 12.683 | ||
EPS (TTM) ($) | -15.512 | ||
Beta | 2.2 | ||
Volatility % | 103.94 | ||
14-Day RSI | 37.29 | ||
14-Day ATR ($) | 0.878243 | ||
20-Day SMA ($) | 13.583 | ||
12-1 Month Momentum % | 82.15 | ||
52-Week Range ($) | 6.13 - 30.958 | ||
Shares Outstanding (Mil) | 59.97 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Immunome Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Immunome Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Immunome Inc Frequently Asked Questions
What is Immunome Inc(IMNM)'s stock price today?
The current price of IMNM is $12.12. The 52 week high of IMNM is $30.96 and 52 week low is $6.13.
When is next earnings date of Immunome Inc(IMNM)?
The next earnings date of Immunome Inc(IMNM) is 2024-08-09 Est..
Does Immunome Inc(IMNM) pay dividends? If so, how much?
Immunome Inc(IMNM) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |